# Business Model - Fair Underwriting

## ðŸ’¼ Revenue Streams

### 1. B2B Partnerships (Primary Revenue - 80-85%)

#### Life Insurance Companies

**Annual subscription per enrolled customer**

- **Base AAT Monitoring Package**: $120-180/customer/year
  - Quarterly or annual AAT level testing
  - SERPINA1 gene mutation identification (one-time)
  - Health alerts and monitoring
  - Basic customer portal access

- **Advanced DNA Sequencing Package**: $500-1,200/customer (one-time + $100-200/year updates)
  - Full genome or exome sequencing
  - Comprehensive genetic health risk assessment
  - Annual updates on new genetic discoveries
  - Enhanced portal features

**Pricing Tiers by Volume**:

- **Starter** (< 1,000 customers): $180/customer/year
- **Growth** (1,000-10,000): $150/customer/year
- **Enterprise** (10,000-50,000): $130/customer/year
- **Enterprise Plus** (50,000+): $120/customer/year + custom features

#### Health Insurance Companies

**Per-member-per-month (PMPM) fees**

- **Preventive Care Tier**: $8-15 PMPM
  - Annual AAT monitoring
  - Basic health insights
  - Integration with existing wellness programs

- **Comprehensive Monitoring Tier**: $20-35 PMPM
  - Quarterly AAT monitoring
  - Full genetic analysis
  - Real-time health alerts
  - Care coordination support
  - Claims integration

**Additional Services**:

- Population health analytics: +$2-5 PMPM
- Care management integration: +$3-7 PMPM
- Pharmacy benefit integration: +$1-3 PMPM

#### Wellness Organizations

**Tiered partnership fees**

- **Small** (< 5,000 members)
  - Flat fee: $10,000-25,000/year
  - Per-test fee: $40-60/test
  - Basic reporting dashboard

- **Medium** (5,000-50,000 members)
  - Flat fee: $50,000-150,000/year
  - Reduced per-test: $25-40/test
  - Advanced analytics
  - Co-branding options

- **Enterprise** (50,000+ members)
  - Custom pricing (typically $200,000-500,000/year)
  - Minimal per-test fees ($15-25/test)
  - White-label options
  - Dedicated account management
  - Custom integration

### 2. Individual Testing (Secondary Revenue - 10-15%)

#### Direct-to-Consumer

- **Single AAT Test**: $49-89/test
- **AAT + SERPINA1 Analysis**: $149-199 (one-time)
- **Full DNA Sequencing**: $599-1,299 (one-time)

#### Subscription Models

- **Bronze** (Annual AAT): $299/year
  - 1 AAT test per year
  - Basic health insights
  - Portal access

- **Silver** (Quarterly AAT): $499/year
  - 4 AAT tests per year
  - Enhanced insights
  - Priority support

- **Gold** (Premium): $999/year
  - Quarterly AAT testing
  - Full DNA sequencing (included)
  - Genetic counselor consultations (2/year)
  - All premium features

### 3. Data Insights Platform (Future Revenue - 5-10%)

#### Research Data Licensing

- **Aggregated data sets**: $50,000-250,000/dataset
- **Annual subscriptions**: $100,000-500,000/year
- **Custom research projects**: $250,000-1M+ per project

#### Pharmaceutical Partnerships

- **Clinical trial recruitment**: $500-2,000 per enrolled participant
- **Biomarker validation studies**: $500,000-2M per study
- **Drug development collaborations**: $1M-10M+ (milestone-based)

#### Academic Research

- **University partnerships**: $25,000-100,000/year
- **Research grants**: Variable
- **Publication co-authorship**: Revenue share on grants

### 4. Certification Program (Revenue - 2-5%)

#### Badge Licensing

- **Bronze Badge**: $5,000/year
- **Silver Badge**: $10,000/year
- **Gold Badge**: $20,000/year
- **Platinum Badge**: $25,000-50,000/year (includes premium support)

#### Technology Services

- **Badge verification API**: $500-2,000/month
- **Public statistics dashboard**: $1,000-5,000/year
- **White-label badge customization**: $10,000-25,000 (one-time)
- **Integration consulting**: $150-300/hour

---

## ðŸ“ˆ Financial Projections

### Year 1: Pilot & Foundation

**Focus**: Platform development, pilot partnerships, regulatory approval

| Metric               | Conservative | Moderate    | Optimistic |
| -------------------- | ------------ | ----------- | ---------- |
| Partners             | 3            | 4           | 5          |
| Enrolled Customers   | 1,000        | 1,500       | 2,500      |
| **Revenue**          | **$150K**    | **$250K**   | **$400K**  |
| - B2B Partnerships   | $120K        | $200K       | $340K      |
| - Individual Testing | $25K         | $40K        | $50K       |
| - Certification      | $5K          | $10K        | $10K       |
| **Expenses**         | **$1.8M**    | **$1.9M**   | **$2.0M**  |
| - Development        | $800K        | $800K       | $800K      |
| - Lab Setup          | $200K        | $200K       | $200K      |
| - Regulatory/Legal   | $150K        | $150K       | $150K      |
| - Operations         | $400K        | $450K       | $500K      |
| - Marketing          | $250K        | $300K       | $350K      |
| **Net**              | **-$1.65M**  | **-$1.65M** | **-$1.6M** |

**Funding Need**: $2-3M seed round

### Year 2: Market Entry

**Focus**: Partner acquisition, market validation, customer growth

| Metric               | Conservative | Moderate   | Optimistic |
| -------------------- | ------------ | ---------- | ---------- |
| Partners             | 12           | 18         | 25         |
| Enrolled Customers   | 15,000       | 22,000     | 30,000     |
| **Revenue**          | **$2.2M**    | **$3.5M**  | **$5.0M**  |
| - B2B Partnerships   | $1.9M        | $3.0M      | $4.3M      |
| - Individual Testing | $250K        | $400K      | $550K      |
| - Certification      | $50K         | $100K      | $150K      |
| **Expenses**         | **$2.8M**    | **$3.2M**  | **$4.0M**  |
| - Personnel          | $1.2M        | $1.4M      | $1.7M      |
| - Lab Operations     | $600K        | $750K      | $1.0M      |
| - Sales & Marketing  | $700K        | $800K      | $1.0M      |
| - Infrastructure     | $300K        | $250K      | $300K      |
| **Net**              | **-$600K**   | **+$300K** | **+$1.0M** |

**Funding Need**: $10-15M Series A (if not profitable)

### Year 3: Growth & Scale

**Focus**: Scaling operations, major partnerships, national expansion

| Metric               | Conservative | Moderate  | Optimistic |
| -------------------- | ------------ | --------- | ---------- |
| Partners             | 40           | 60        | 75         |
| Enrolled Customers   | 80,000       | 140,000   | 200,000    |
| **Revenue**          | **$12M**     | **$22M**  | **$35M**   |
| - B2B Partnerships   | $10.2M       | $18.5M    | $29.5M     |
| - Individual Testing | $1.2M        | $2.5M     | $4.0M      |
| - Data Insights      | $300K        | $600K     | $1.0M      |
| - Certification      | $300K        | $400K     | $500K      |
| **Expenses**         | **$8.5M**    | **$12M**  | **$15M**   |
| - Personnel          | $3.5M        | $5.0M     | $6.5M      |
| - Lab Operations     | $2.5M        | $3.5M     | $4.5M      |
| - Sales & Marketing  | $1.5M        | $2.0M     | $2.5M      |
| - Infrastructure     | $1.0M        | $1.5M     | $1.5M      |
| **Net**              | **+$3.5M**   | **+$10M** | **+$20M**  |

**Funding**: Operating from revenue or Series B ($30-50M) for acceleration

### Year 5: Market Leadership

**Focus**: Market dominance, international expansion, platform expansion

| Metric               | Conservative | Moderate  | Optimistic |
| -------------------- | ------------ | --------- | ---------- |
| Partners             | 150          | 225       | 300        |
| Enrolled Customers   | 750K         | 1.25M     | 2M         |
| **Revenue**          | **$100M**    | **$160M** | **$250M**  |
| - B2B Partnerships   | $82M         | $130M     | $200M      |
| - Individual Testing | $10M         | $18M      | $30M       |
| - Data Insights      | $5M          | $8M       | $15M       |
| - Certification      | $3M          | $4M       | $5M        |
| **Expenses**         | **$50M**     | **$70M**  | **$100M**  |
| - Personnel          | $20M         | $28M      | $40M       |
| - Lab Operations     | $15M         | $21M      | $30M       |
| - Sales & Marketing  | $8M          | $12M      | $18M       |
| - Infrastructure     | $7M          | $9M       | $12M       |
| **Net**              | **+$50M**    | **+$90M** | **+$150M** |

**Valuation**: $500M-2B (depending on growth trajectory)

---

## ðŸ’° Unit Economics

### B2B Partnership Economics

#### Life Insurance Partner (Average)

**Customer Acquisition Cost (CAC)**: $200-300 per partner relationship (amortized)

- Sales cycle: 6-12 months
- Sales team cost per deal: $30K-50K
- Average initial enrollment: 200-500 customers

**Customer Value**:

- Annual revenue per customer: $150 (average)
- Average customer retention: 5-8 years
- Lifetime value (LTV): $750-1,200
- **LTV:CAC Ratio**: 25-40:1 (excellent)

**Partner Retention**:

- Year 1: 85%
- Year 2: 90%
- Year 3+: 95%

#### Health Insurance Partner (Average)

**CAC**: $500-800 per partner relationship (amortized)

- Sales cycle: 9-18 months
- Higher compliance requirements
- Average initial enrollment: 1,000-5,000 members

**Customer Value**:

- Monthly revenue per member: $20 (average)
- Annual revenue: $240
- Average retention: 3-5 years
- LTV: $720-1,200
- **LTV:CAC Ratio**: 9-15:1 (good)

### Direct-to-Consumer Economics

**CAC**: $30-60 per customer

- Digital marketing: $25-40
- Content marketing: $5-10
- Referral program: $5-10

**Customer Value**:

- First purchase: $89 (average)
- Repeat purchase rate: 40%
- Average lifetime purchases: 2.8
- LTV: $249
- **LTV:CAC Ratio**: 4-8:1 (healthy)

---

## ðŸ“Š Key Assumptions

### Market Penetration

- **Year 1**: 0.001% of addressable market
- **Year 3**: 0.05% of addressable market
- **Year 5**: 0.3% of addressable market
- **Year 10**: 2-5% of addressable market

### Pricing Stability

- Prices remain stable Years 1-3
- 5-10% price reduction Years 4-5 (economies of scale)
- Offset by premium features and upsells

### Cost Structure

- Lab costs: $15-25 per AAT test (decreasing with volume)
- DNA sequencing: $200-400 per test (decreasing with technology)
- Gross margin: 60-75% (improving with scale)

### Growth Assumptions

- Customer acquisition: 50-100% growth annually (Years 2-5)
- Partner acquisition: 100-200% growth annually (Years 2-3)
- Churn rate: 5-15% annually (improving with maturity)

---

## ðŸŽ¯ Revenue Optimization Strategies

### 1. Upsell Opportunities

- Basic â†’ Premium testing (30% conversion target)
- Annual â†’ Quarterly testing (20% conversion)
- AAT only â†’ Full DNA sequencing (15% conversion)
- Individual â†’ Family plans (25% conversion)

### 2. Cross-Sell Opportunities

- Integration with other Velox products (PrivacyPulse, MailGuard)
- Wellness coaching services
- Genetic counseling packages
- Family testing bundles

### 3. Partnership Bonuses

- Volume-based incentives for partners
- Co-marketing rebates
- Referral fees for partner-to-partner introductions
- Research participation incentives

### 4. Platform Extensions

- White-label solutions (higher margins)
- API access tiers
- Custom integration services
- Data analytics consulting

---

## ðŸ’¡ Profitability Path

### Break-Even Analysis

**Monthly Fixed Costs** (Year 2): ~$250K

- Personnel: $115K
- Infrastructure: $25K
- Overhead: $60K
- Marketing: $50K

**Variable Costs per Customer** (Year 2): ~$30

- Lab testing: $20
- Customer support: $5
- Transaction costs: $5

**Average Revenue per Customer** (B2B): $12.50/month ($150/year)

**Break-Even Customers**: ~20,000 enrolled customers

- Expected achievement: Month 18-24

### Path to Profitability

1. **Pilot Phase** (Months 1-12): Investment mode, -$1.5M
2. **Growth Phase** (Months 13-24): Approach break-even, -$600K to +$300K
3. **Scale Phase** (Months 25-36): Profitable, +$3M-10M
4. **Optimization Phase** (Year 4-5): High margins, +$50M-150M

---

## ðŸ“ˆ Exit Scenarios

### Acquisition Targets (Year 4-7)

- **Insurance Companies**: $500M-1B
- **Health Tech Companies**: $800M-2B
- **Genetic Testing Companies**: $600M-1.5B
- **Big Tech (health divisions)**: $1B-3B

### IPO Scenario (Year 5-7)

- **Valuation**: $1B-5B
- **Requirements**: $200M+ revenue, profitable, clear growth path
- **Comparable Companies**: 23andMe, Invitae, Myriad Genetics

### Private Equity (Year 6-8)

- **Valuation**: $800M-2B
- **Focus**: Cash flow optimization, bolt-on acquisitions

---

**Document Version**: 1.0
**Last Updated**: November 7, 2025
**Next Review**: Q2 2026
